Advertisement

Embryo transfer strategy and therapeutic options in infertile patients with thin endometrium: a systematic review

  • Noemie Ranisavljevic
  • Jade Raad
  • Tal Anahory
  • Michaël Grynberg
  • Charlotte SonigoEmail author
Review
  • 36 Downloads

Abstract

Human endometrium has a key role in implantation process. The measurement of endometrial thickness is the most commonly used in clinical practice. Managing patients with thin endometrium still represents a major challenge for clinicians. The objective of this systematic review was to investigate all available interventions to improve endometrial thickness (EMT) in women with history of thin endometrium undergoing fresh or frozen-thawed embryo transfers (ET). We performed a comprehensive search of relevant studies from January 1978 to February 2018. The different strategies were categorized as hormonal, vascular, and growth factor approaches and specifically analyzed according to the type of ET. Thirty-one studies were included. Overall, quality of the evidence ranged from very low to moderate, with only few randomized controlled trials that support the use of either GnRH analogues in fresh ET or sildenafil in frozen ET for enhancing endometrial growth. Besides, intensified estradiol administration is a common approach that might improve EMT in frozen ET. The present review evidences the paucity of reliable data regarding the efficiency of different interventions aiming at increasing EMT before fresh or frozen-thawed ET. Robust and high-quality randomized controlled trials are still needed before guidelines can be established.

Keywords

Endometrial thickness Embryo transfer Pregnancy In vitro fertilization 

Notes

Acknowledgments

We want to thank Elisangela Arbo-Jouhaud for organizing our workshop group meetings and for her guidance. We are also grateful to Monitoring Force, especially Solene Languille and Bernadette Darne, for their assistance in literature search and for their advice.

Authors’ contributions

T.A. and M.G. were involved in the conception of the review.

N.R., J.R., and C.S. contributed to data collection and extraction, as well as drafting the article.

All authors analyzed and interpreted the data.

T.A. and M.G. had a critical revision of the manuscript.

All authors approved the final version to be published.

Funding information

This research was financially supported by Gedeon Richter France who provided methodological support through Monitoring Force.

Compliance with ethical standards

Competing interests

The authors declare that they have no competing interests.

References

  1. 1.
    Miravet-Valenciano JA, Rincon-Bertolin A, Vilella F, Simon C. Understanding and improving endometrial receptivity. Curr Opin Obstet Gynecol. 2015;27:187–92.CrossRefGoogle Scholar
  2. 2.
    von Grothusen C, Lalitkumar S, Boggavarapu NR, Gemzell-Danielsson K, Lalitkumar PG. Recent advances in understanding endometrial receptivity: molecular basis and clinical applications. Am J Reprod Immunol N Y N 1989. 2014;72:148–57.Google Scholar
  3. 3.
    Momeni M, Rahbar MH, Kovanci E. A meta-analysis of the relationship between endometrial thickness and outcome of in vitro fertilization cycles. J Hum Reprod Sci. 2011;4:130–7.CrossRefGoogle Scholar
  4. 4.
    Liu KE, Hartman M, Hartman A, Luo Z-C, Mahutte N. The impact of a thin endometrial lining on fresh and frozen-thaw IVF outcomes: an analysis of over 40 000 embryo transfers. Hum Reprod. 2018;33:1883–8.CrossRefGoogle Scholar
  5. 5.
    Chung K, Coutifaris C, Chalian R, Lin K, Ratcliffe SJ, Castelbaum AJ, et al. Factors influencing adverse perinatal outcomes in pregnancies achieved through use of in vitro fertilization. Fertil Steril. 2006;86:1634–41.CrossRefGoogle Scholar
  6. 6.
    Yuan X, Saravelos SH, Wang Q, Xu Y, Li T-C, Zhou C. Endometrial thickness as a predictor of pregnancy outcomes in 10787 fresh IVF-ICSI cycles. Reprod BioMed Online. 2016;33:197–205.CrossRefGoogle Scholar
  7. 7.
    Chen M-J, Yang J-H, Peng F-H, Chen S-U, Ho H-N, Yang Y-S. Extended estrogen administration for women with thin endometrium in frozen-thawed in-vitro fertilization programs. J Assist Reprod Genet. 2006;23:337–42.CrossRefGoogle Scholar
  8. 8.
    El-Toukhy T, Coomarasamy A, Khairy M, Sunkara K, Seed P, Khalaf Y, et al. The relationship between endometrial thickness and outcome of medicated frozen embryo replacement cycles. Fertil Steril. 2008;89:832–9.CrossRefGoogle Scholar
  9. 9.
    Kumbak B, Erden HF, Tosun S, Akbas H, Ulug U, Bahçeci M. Outcome of assisted reproduction treatment in patients with endometrial thickness less than 7 mm. Reprod BioMed Online. 2009;18:79–84.CrossRefGoogle Scholar
  10. 10.
    Bozdag G, Esinler I, Yarali H. The impact of endometrial thickness and texture on intracytoplasmic sperm injection outcome. J Reprod Med. 2009;54:303–11.Google Scholar
  11. 11.
    Okohue JE, Onuh SO, Ebeigbe P, Shaibu I, Wada I, Ikimalo JI, et al. The effect of endometrial thickness on in vitro fertilization (IVF)-embryo transfer/intracytoplasmic sperm injection (ICSI) outcome. Afr J Reprod Health. 2009;13:113–21.Google Scholar
  12. 12.
    Kasius A, Smit JG, Torrance HL, Eijkemans MJC, Mol BW, Opmeer BC, et al. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:530–41.CrossRefGoogle Scholar
  13. 13.
    Ribeiro VC, Santos-Ribeiro S, De Munck N, Drakopoulos P, Polyzos NP, Schutyser V, et al. Should we continue to measure endometrial thickness in modern-day medicine? The effect on live birth rates and birth weight. Reprod BioMed Online. 2018;36:416–26.CrossRefGoogle Scholar
  14. 14.
    Groothuis PG, Dassen HHNM, Romano A, Punyadeera C. Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human. Hum Reprod Update. 2007;13:405–17.CrossRefGoogle Scholar
  15. 15.
    Hapangama DK, Kamal AM, Bulmer JN. Estrogen receptor β: the guardian of the endometrium. Hum Reprod Update. 2015;21:174–93.CrossRefGoogle Scholar
  16. 16.
    Check JH, Graziano V, Lee G, Nazari A, Choe JK, Dietterich C. Neither sildenafil nor vaginal estradiol improves endometrial thickness in women with thin endometria after taking oral estradiol in graduating dosages. Clin Exp Obstet Gynecol. 2004;31:99–102.Google Scholar
  17. 17.
    Liao X, Li Z, Dong X, Zhang H. Comparison between oral and vaginal estrogen usage in inadequate endometrial patients for frozen-thawed blastocysts transfer. Int J Clin Exp Pathol. 2014;7:6992–7.Google Scholar
  18. 18.
    Dmowski WP, Michalowska J, Rana N, Friberg J, McGill-Johnson E, DeOrio L. Subcutaneous estradiol pellets for endometrial preparation in donor oocyte recipients with a poor endometrial response. J Assist Reprod Genet. 1997;14:139–44.CrossRefGoogle Scholar
  19. 19.
    Zolghadri J, Haghbin H, Dadras N, Behdin S. Vagifem is superior to vaginal Premarin in induction of endometrial thickness in the frozen-thawed cycle patients with refractory endometria: a randomized clinical trial. Iran J Reprod Med. 2014;12:415–20.Google Scholar
  20. 20.
    Papanikolaou EG, Kyrou D, Zervakakou G, Paggou E, Humaidan P. Follicular HCG endometrium priming for IVF patients experiencing resisting thin endometrium. A proof of concept study. J Assist Reprod Genet. 2013;30:1341–5.CrossRefGoogle Scholar
  21. 21.
    Davar R, Miraj S, Farid MM. Effect of adding human chorionic gonadotropin to frozen thawed embryo transfer cycles with history of thin endometrium. Int J Reprod Biomed Yazd Iran. 2016;14:53–6.CrossRefGoogle Scholar
  22. 22.
    Qublan H, Qublah H, Amarin Z, Al-Qudah M, Al-Quda M, Diab F, et al. Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of <or=7 mm on day of egg retrieval. Hum Fertil (Camb). 2008;11:43–7.CrossRefGoogle Scholar
  23. 23.
    Paulson RJ. Hormonal induction of endometrial receptivity. Fertil Steril. 2011;96:530–5.CrossRefGoogle Scholar
  24. 24.
    Tourgeman DE, Slater CC, Stanczyk FZ, Paulson RJ. Endocrine and clinical effects of micronized estradiol administered vaginally or orally. Fertil Steril. 2001;75:200–2.CrossRefGoogle Scholar
  25. 25.
    Perrier d’Hauterive S, Berndt S, Tsampalas M, Charlet-Renard C, Dubois M, Bourgain C, et al. Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation? Gynecol Obstet Investig. 2007;64:156–60.CrossRefGoogle Scholar
  26. 26.
    Licht P, Russu V, Wildt L. On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation. Semin Reprod Med. 2001;19:37–47.CrossRefGoogle Scholar
  27. 27.
    Licht P, von Wolff M, Berkholz A, Wildt L. Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril. 2003;79(Suppl 1):718–23.CrossRefGoogle Scholar
  28. 28.
    Prapas N, Tavaniotou A, Panagiotidis Y, Prapa S, Kasapi E, Goudakou M, et al. Low-dose human chorionic gonadotropin during the proliferative phase may adversely affect endometrial receptivity in oocyte recipients. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2009;25:53–9.CrossRefGoogle Scholar
  29. 29.
    Glujovsky D, Pesce R, Fiszbajn G, Sueldo C, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev. 2010;1:CD006359.Google Scholar
  30. 30.
    Tesarik J, Hazout A, Mendoza C. Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Hum Reprod. 2004;19:1176–80.CrossRefGoogle Scholar
  31. 31.
    Oliveira JBA, Baruffi R, Petersen CG, Mauri AL, Cavagna M, Franco JG. Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reprod Biol Endocrinol. 2010;8:107.CrossRefGoogle Scholar
  32. 32.
    van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015;7:CD009154.Google Scholar
  33. 33.
    al MI et. Pathophysiologic features of “thin” endometrium. - PubMed - NCBI [Internet]. [cited 2019 Mar 29]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/?term=Pathophysiologic+features+of+%22thin%22+endometrium.
  34. 34.
    Sher G, Fisch JD. Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod. 2000;15:806–9.CrossRefGoogle Scholar
  35. 35.
    Sher G, Fisch JD. Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril. 2002;78:1073–6.CrossRefGoogle Scholar
  36. 36.
    Dehghani Firouzabadi R, Davar R, Hojjat F, Mahdavi M. Effect of sildenafil citrate on endometrial preparation and outcome of frozen-thawed embryo transfer cycles: a randomized clinical trial. Iran J Reprod Med. 2013;11:151–8.Google Scholar
  37. 37.
    Kim KR. J Womens Med. ed Hee Sun Lee; 2010.Google Scholar
  38. 38.
    Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: prospective, randomized study. Fertil Steril. 1997;68:927–30.CrossRefGoogle Scholar
  39. 39.
    Lédée-Bataille N, Olivennes F, Lefaix J-L, Chaouat G, Frydman R, Delanian S. Combined treatment by pentoxifylline and tocopherol for recipient women with a thin endometrium enrolled in an oocyte donation programme. Hum Reprod. 2002;17:1249–53.CrossRefGoogle Scholar
  40. 40.
    Acharya S, Yasmin E, Balen AH. The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies--a report of 20 cases. Hum Fertil Camb Engl. 2009;12:198–203.CrossRefGoogle Scholar
  41. 41.
    Bodombossou-Djobo MMA, Zheng C, Chen S, Yang D. Neuromuscular electrical stimulation and biofeedback therapy may improve endometrial growth for patients with thin endometrium during frozen-thawed embryo transfer: a preliminary report. Reprod Biol Endocrinol. 2011;9:122.CrossRefGoogle Scholar
  42. 42.
    Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden PR. The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod. 1994;9:1954–7.CrossRefGoogle Scholar
  43. 43.
    Dentali F, Ageno W, Rezoagli E, Rancan E, Squizzato A, Middeldorp S, et al. Low-dose aspirin for in vitro fertilization or intracytoplasmic sperm injection: a systematic review and a meta-analysis of the literature. J Thromb Haemost. 2012;10:2075–85.CrossRefGoogle Scholar
  44. 44.
    Khairy M, Banerjee K, El-Toukhy T, Coomarasamy A, Khalaf Y. Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril. 2007;88:822–31.CrossRefGoogle Scholar
  45. 45.
    Giudice LC. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril. 1994;61:1–17.CrossRefGoogle Scholar
  46. 46.
    Gleicher N, Kim A, Michaeli T, Lee H-J, Shohat-Tal A, Lazzaroni E, et al. A pilot cohort study of granulocyte colony-stimulating factor in the treatment of unresponsive thin endometrium resistant to standard therapies. Hum Reprod. 2013;28:172–7.CrossRefGoogle Scholar
  47. 47.
    Kunicki M, Łukaszuk K, Woclawek-Potocka I, Liss J, Kulwikowska P, Szczyptańska J. Evaluation of granulocyte colony-stimulating factor effects on treatment-resistant thin endometrium in women undergoing in vitro fertilization. Biomed Res Int. 2014;2014:913235.CrossRefGoogle Scholar
  48. 48.
    Tehraninejad E, Davari Tanha F, Asadi E, Kamali K, Aziminikoo E, Rezayof E. G-CSF intrauterine for thin endometrium, and pregnancy outcome. J Family Reprod Health. 2015;9:107–12.Google Scholar
  49. 49.
    Lee D, Jo JD, Kim SK, Jee BC, Kim SH. The efficacy of intrauterine instillation of granulocyte colony-stimulating factor in infertile women with a thin endometrium: a pilot study. Clin Exp Reprod Med. 2016;43:240–6.CrossRefGoogle Scholar
  50. 50.
    Sarvi F, Arabahmadi M, Alleyassin A, Aghahosseini M, Ghasemi M. Effect of increased endometrial thickness and implantation rate by granulocyte colony-stimulating factor on unresponsive thin endometrium in fresh in vitro fertilization cycles: a randomized clinical trial. Obstet Gynecol Int. 2017;2017:3596079.CrossRefGoogle Scholar
  51. 51.
    Gleicher N, Vidali A, Barad DH. Successful treatment of unresponsive thin endometrium. Fertil Steril. 2011;95:2123.e13–7.CrossRefGoogle Scholar
  52. 52.
    Li Y, Pan P, Chen X, Li L, Li Y, Yang D. Granulocyte colony-stimulating factor administration for infertile women with thin endometrium in frozen embryo transfer program. Reprod Sci Thousand Oaks Calif. 2014;21:381–5.CrossRefGoogle Scholar
  53. 53.
    Shah J, Gangadharan A, Shah V. Effect of intrauterine instillation of granulocyte colony-stimulating factor on endometrial thickness and clinical pregnancy rate in women undergoing in vitro fertilization cycles: an observational cohort study. 2014;3:100-106.Google Scholar
  54. 54.
    Eftekhar M, Sayadi M, Arabjahvani F. Transvaginal perfusion of G-CSF for infertile women with thin endometrium in frozen ET program: a non-randomized clinical trial. Iran J Reprod Med. 2014;12:661–6.Google Scholar
  55. 55.
    Xu B, Zhang Q, Hao J, Xu D, Li Y. Two protocols to treat thin endometrium with granulocyte colony-stimulating factor during frozen embryo transfer cycles. Reprod BioMed Online. 2015;30:349–58.CrossRefGoogle Scholar
  56. 56.
    Check JH, Choe JK, Summers-Chase D. Failure to increase the thickness of thin endometria with intrauterine infusion of granulocyte colony stimulating factor (G-CSF). Clin Exp Obstet Gynecol. 2016;43:332–3.Google Scholar
  57. 57.
    Mishra VV, Choudhary S, Sharma U, Aggarwal R, Agarwal R, Gandhi K, et al. Effects of granulocyte colony-stimulating factor (GCSF) on persistent thin endometrium in frozen embryo transfer (FET) cycles. J Obstet Gynaecol India. 2016;66:407–11.CrossRefGoogle Scholar
  58. 58.
    Kunicki M, Łukaszuk K, Liss J, Skowrońska P, Szczyptańska J. Granulocyte colony stimulating factor treatment of resistant thin endometrium in women with frozen-thawed blastocyst transfer. Syst Biol Reprod Med. 2017;63:49–57.CrossRefGoogle Scholar
  59. 59.
    Chang Y, Li J, Chen Y, Wei L, Yang X, Shi Y, et al. Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. Int J Clin Exp Med. 2015;8:1286–90.Google Scholar
  60. 60.
    Zadehmodarres S, Salehpour S, Saharkhiz N, Nazari L. Treatment of thin endometrium with autologous platelet-rich plasma: a pilot study. JBRA Assist Reprod. 2017;21:54–6.CrossRefGoogle Scholar
  61. 61.
    Tandulwadkar SR, Naralkar MV, Surana AD, Selvakarthick M, Kharat AH. Autologous intrauterine platelet-rich plasma instillation for suboptimal endometrium in frozen embryo transfer cycles: a pilot study. J Hum Reprod Sci. 2017;10:208–12.CrossRefGoogle Scholar
  62. 62.
    Jensen JR, Witz CA, Schenken RS, Tekmal RR. A potential role for colony-stimulating factor 1 in the genesis of the early endometriotic lesion. Fertil Steril. 2010;93:251–6.CrossRefGoogle Scholar
  63. 63.
    Alsousou J, Ali A, Willett K, Harrison P. The role of platelet-rich plasma in tissue regeneration. Platelets. 2013;24:173–82.CrossRefGoogle Scholar
  64. 64.
    Kim H, Shin JE, Koo HS, Kwon H, Choi DH, Kim JH. Effect of autologous platelet-rich plasma treatment on refractory thin endometrium during the frozen embryo transfer cycle: a pilot study. Front Endocrinol. 2019;10:61.CrossRefGoogle Scholar
  65. 65.
    Chang Y, Li J, Wei L-N, Pang J, Chen J, Liang X. Autologous platelet-rich plasma infusion improves clinical pregnancy rate in frozen embryo transfer cycles for women with thin endometrium. Medicine (Baltimore). 2019;98:e14062.CrossRefGoogle Scholar
  66. 66.
    Eftekhar M, Neghab N, Naghshineh E, Khani P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol. 2018;57:810–3.CrossRefGoogle Scholar
  67. 67.
    Wang X, Liu L, Mou S, Zhao H, Fang J, Xiang Y, et al. Investigation of platelet-rich plasma in increasing proliferation and migration of endometrial mesenchymal stem cells and improving pregnancy outcome of patients with thin endometrium. J Cell Biochem. 2018.Google Scholar
  68. 68.
    Wong KM, van Wely M, Mol F, Repping S, Mastenbroek S. Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database Syst Rev. 2017;3:CD011184.Google Scholar
  69. 69.
    Li J, Mo S, Chen Y. The effect of G-CSF on infertile women undergoing IVF treatment: a meta-analysis. Syst Biol Reprod Med. 2017;63:239–47.CrossRefGoogle Scholar
  70. 70.
    Xie Y, Zhang T, Tian Z, Zhang J, Wang W, Zhang H, et al. Efficacy of intrauterine perfusion of granulocyte colony-stimulating factor (G-CSF) for infertile women with thin endometrium: a systematic review and meta-analysis. Am J Reprod Immunol. 1989;2017:78.Google Scholar
  71. 71.
    Gargett CE, Ye L. Endometrial reconstruction from stem cells. Fertil Steril. 2012;98:11–20.CrossRefGoogle Scholar
  72. 72.
    Santamaria X, Cabanillas S, Cervelló I, Arbona C, Raga F, Ferro J, et al. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman’s syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod. 2016;31:1087–96.CrossRefGoogle Scholar
  73. 73.
    Nagori CB, Panchal SY, Patel H. Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman’s syndrome. J Hum Reprod Sci. 2011;4:43–8.CrossRefGoogle Scholar
  74. 74.
    Papanikolaou EG, Pados G, Grimbizis G, Bili E, Kyriazi L, Polyzos NP, et al. GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study. Hum Reprod. 2012;27:1822–8.CrossRefGoogle Scholar
  75. 75.
    Jimenez PT, Schon SB, Odem RR, Ratts VS, Jungheim ES. A retrospective cross-sectional study: fresh cycle endometrial thickness is a sensitive predictor of inadequate endometrial thickness in frozen embryo transfer cycles. Reprod Biol Endocrinol. 2013;11:35.CrossRefGoogle Scholar
  76. 76.
    Gupta P, Banker M, Patel P, Joshi B. A study of recipient related predictors of success in oocyte donation program. J Hum Reprod Sci. 2012;5:252–7.CrossRefGoogle Scholar
  77. 77.
    Spandorfer SD, Arrendondo-Soberon F, Loret de Mola JR, Feinberg RF. Reliability of intraobserver and interobserver sonographic endometrial stripe thickness measurements. Fertil Steril. 1998;70:152–4.CrossRefGoogle Scholar
  78. 78.
    Delisle MF, Villeneuve M, Boulvain M. Measurement of endometrial thickness with transvaginal ultrasonography: is it reproducible? J Ultrasound Med Off J Am Inst Ultrasound Med. 1998;17:481–484-486.Google Scholar
  79. 79.
    Hershko-Klement A, Tepper R. Ultrasound in assisted reproduction: a call to fill the endometrial gap. Fertil Steril. 2016;105:1394–1402.e4.CrossRefGoogle Scholar
  80. 80.
    Chen S-L, Wu F-R, Luo C, Chen X, Shi X-Y, Zheng H-Y, et al. Combined analysis of endometrial thickness and pattern in predicting outcome of in vitro fertilization and embryo transfer: a retrospective cohort study. Reprod Biol Endocrinol. 2010;8:30.CrossRefGoogle Scholar
  81. 81.
    Zollner U, Specketer M-T, Dietl J, Zollner K-P. 3D-endometrial volume and outcome of cryopreserved embryo replacement cycles. Arch Gynecol Obstet. 2012;286:517–23.CrossRefGoogle Scholar
  82. 82.
    Joo J-K, Jeong J-E, Kim C-W, Lee K-S. Quantitative assessment of endometrial volume and uterine vascularity and pregnancy outcome in frozen-thawed embryo transfer cycles. J Reprod Med. 2016;61:133–8.Google Scholar
  83. 83.
    Dechaud H, Bessueille E, Bousquet P-J, Reyftmann L, Hamamah S, Hedon B. Optimal timing of ultrasonographic and Doppler evaluation of uterine receptivity to implantation. Reprod BioMed Online. 2008;16:368–75.CrossRefGoogle Scholar
  84. 84.
    Zhao J, Zhang Q, Wang Y, Li Y. Endometrial pattern, thickness and growth in predicting pregnancy outcome following 3319 IVF cycle. Reprod BioMed Online. 2014;29:291–8.CrossRefGoogle Scholar
  85. 85.
    Coelho Neto MA, Martins WP, Lima MLS, Barbosa M a P, Nastri CO, Ferriani RA, et al. Ovarian response is a better predictor of clinical pregnancy rate following embryo transfer than is thin endometrium or presence of an endometrioma. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2015;46:501–5.CrossRefGoogle Scholar
  86. 86.
    Kinay T, Tasci Y, Dilbaz S, Cinar O, Demir B, Haberal A. The relationship between endometrial thickness and pregnancy rates in GnRH antagonist down-regulated ICSI cycles. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2010;26:833–7.CrossRefGoogle Scholar
  87. 87.
    Remohí J, Ardiles G, García-Velasco JA, Gaitán P, Simón C, Pellicer A. Endometrial thickness and serum oestradiol concentrations as predictors of outcome in oocyte donation. Hum Reprod. 1997;12:2271–6.CrossRefGoogle Scholar
  88. 88.
    Sundström P. Establishment of a successful pregnancy following in-vitro fertilization with an endometrial thickness of no more than 4 mm. Hum Reprod. 1998;13:1550–2.CrossRefGoogle Scholar
  89. 89.
    Check JH, Cohen R. Live fetus following embryo transfer in a woman with diminished egg reserve whose maximal endometrial thickness was less than 4 mm. Clin Exp Obstet Gynecol. 2011;38:330–2.Google Scholar
  90. 90.
    Cruz F, Bellver J. Live birth after embryo transfer in an unresponsive thin endometrium. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2014;30:481–4.CrossRefGoogle Scholar
  91. 91.
    Zhang T, Li Z, Ren X, Huang B, Zhu G, Yang W, et al. Endometrial thickness as a predictor of the reproductive outcomes in fresh and frozen embryo transfer cycles: a retrospective cohort study of 1512 IVF cycles with morphologically good-quality blastocyst. Medicine (Baltimore). 2018;97:e9689.CrossRefGoogle Scholar
  92. 92.
    Ma N-Z, Chen L, Dai W, Bu Z-Q, Hu L-L, Sun Y-P. Influence of endometrial thickness on treatment outcomes following in vitro fertilization/intracytoplasmic sperm injection. Reprod Biol Endocrinol. 2017;15:5.CrossRefGoogle Scholar
  93. 93.
    Holden EC, Dodge LE, Sneeringer R, Moragianni VA, Penzias AS, Hacker MR. Thicker endometrial linings are associated with better IVF outcomes: a cohort of 6331 women. Hum Fertil Camb Engl. 2018;21:288–93.CrossRefGoogle Scholar
  94. 94.
    Fang R, Cai L, Xiong F, Chen J, Yang W, Zhao X. The effect of endometrial thickness on the day of hCG administration on pregnancy outcome in the first fresh IVF/ICSI cycle. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 2016;32:473–6.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Noemie Ranisavljevic
    • 1
  • Jade Raad
    • 2
  • Tal Anahory
    • 1
  • Michaël Grynberg
    • 2
    • 3
    • 4
  • Charlotte Sonigo
    • 2
    • 3
    • 5
    Email author
  1. 1.Department of Reproductive MedicineCHU and University of MontpellierMontpellierFrance
  2. 2.Department of Reproductive Medicine and Fertility PreservationHôpital Antoine BéclèreClamartFrance
  3. 3.Université Paris-SudUniversité Paris SaclayLe Kremlin BicêtreFrance
  4. 4.Inserm U1133 Université Paris DiderotParisFrance
  5. 5.Inserm U1185 Université Paris-SudUniversité Paris SaclayLe Kremlin BicêtreFrance

Personalised recommendations